Pathology of combined hepatocellular-cholangiocarcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 9, 2010, Pages 1485-1492

  Yeh, Matthew M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

cholangiocarcinoma; combined hepatocellular cholangiocarcinoma; hepatocellular carcinoma

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 7; GLYPICAN 3;

BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; HEPATOCELLULAR CHOLANGIOCARCINOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER RESECTION; MIXED TUMOR; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; STEM CELL; TREATMENT OUTCOME;

EID: 77956049820     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06430.x     Document Type: Review

References (45)

1. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann. Surg. 1990 211 : 277 287.
2. Aoki K, Takayasu K, Kawano T et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology 1993 18 : 1090 1095.
3. Edmondson HA. Tumors of the Liver and Intrahepatic Bile Ducts. Washington, D.C. : Armed Forces Institute of Pathology, 1958.
4. Maeda T, Adachi E, Kajiyama K, Sugimachi K, Tsuneyoshi M. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum. Pathol. 1995 26 : 956 964.
5. Ishak KG, Anthony PP, Sobin LH, Gibson JB. Histological Typing of Tumours of the Liver, 2nd edn. Berlin; New York : Springer-Verlag, 1994.
6. Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am. J. Pathol. 1949 25 : 647 655.
7. Popper H, Schaffner F. Liver: Structure and Function. New York : Blakiston Division, 1957.
8. Anthony PP. Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans. J. Pathol. 1973 110 : 37 48.
9. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 1985 55 : 124 135.
10. Fujii H, Zhu XG, Matsumoto T et al. Genetic classification of combined hepatocellular-cholangiocarcinoma. Hum. Pathol. 2000 31 : 1011 1017.
11. Cazals-Hatem D, Rebouissou S, Bioulac-Sage P et al. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J. Hepatol. 2004 41 : 292 298.
12. Jarnagin WR, Weber S, Tickoo SK et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002 94 : 2040 2046.
13. Sanada Y, Shiozaki S, Aoki H, Takakura N, Yoshida K, Yamaguchi Y. A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma. Assessment of enhancement patterns on dynamics computed tomography before resection. Hepatol. Res. 2005 32 : 185 195.
14. Goodman ZD, Terracciano LM. Tumours and tumour-like lesions of the liver. In : MacSween RNM, Burt AD, Portmann B, Ferrell LD, eds. MacSween's Pathology of the Liver, 5th edn. London : Churchill Livingstone / Elsevier, 2007 973.
15. Tickoo SK, Zee SY, Obiekwe S et al. Combined hepatocellular- cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. Am. J. Surg. Pathol. 2002 26 : 989 997.
16. Tanaka K, Honna T, Kitano Y et al. Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report. J. Clin. Pathol. 2005 58 : 884 887.
17. Coston WM, Loera S, Lau SK et al. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry. Am. J. Surg. Pathol. 2008 32 : 433 444.
18. Shafizadeh N, Ferrell LD, Kakar S. Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum. Mod. Pathol. 2008 21 : 1011 1018.
19. Wang HL, Anatelli F, Zhai QJ, Adley B, Chuang ST, Yang XJ. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions. Arch. Pathol. Lab. Med. 2008 132 : 1723 1728.
20. Shirakawa H, Kuronuma T, Nishimura Y et al. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. Int. J. Oncol. 2009 34 : 649 656.
21. Ng IO, Shek TW, Nicholls J, Ma LT. Combined hepatocellular- cholangiocarcinoma: a clinicopathological study. J. Gastroenterol. Hepatol. 1998 13 : 34 40.
22. Zuo HQ, Yan LN, Zeng Y et al. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat. Dis. Int. 2007 6 : 161 165.
23. Durnez A, Verslype C, Nevens F et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006 49 : 138 151.
24. Klein WM, Molmenti EP, Colombani PM et al. Primary liver carcinoma arising in people younger than 30 years. Am. J. Clin. Pathol. 2005 124 : 512 518.
25. Wu PC, Fang JW, Lau VK, Lai CL, Lo CK, Lau JY. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am. J. Pathol. 1996 149 : 1167 1175.
26. Yano H, Iemura A, Haramaki M et al. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions. J. Hepatol. 1996 24 : 413 422.
27. Kojiro M, Nakashima T. Pathology of hepatocellular carcinoma. In : Okuda K, Ishak K, eds. Neoplasm of the Liver. Tokyo : Spring-Verlag, 1987 81 104.
28. Kojiro M. Pathomorphology of advanced hepatocellular carcinoma. In : Tobe T, Kameda H, Okudaira M et al. eds. Primary Liver Cancer in Japan. Tokyo : Spring-Verlag. 1992 31 2.
29. Kim H, Park C, Han KH et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J. Hepatol. 2004 40 : 298 304.
30. Tanaka S, Yamamoto T, Tanaka H et al. Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell: immunohistochemical evidence. Hepatol. Res. 2005 32 : 52 7.
31. Theise ND, Yao JL, Harada K et al. Hepatic 'stem cell' malignancies in adults: four cases. Histopathology 2003 43 : 263 271.
32. Komuta M, Spee B, Vander Borght S et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology 2008 47 : 1544 1556.
33. Shiota K, Taguchi J, Nakashima O, Nakashima M, Kojiro M. Clinicopathologic study on cholangiolocellular carcinoma. Oncol. Rep. 2001 8 : 263 268.
34. Steiner PE, Higginson J. Cholangiolocellular carcinoma of the liver. Cancer 1959 12 : 753 759.
35. Andersen JB, Loi R, Perra A et al. Progenitor-derived hepatocellular carcinoma model in the rat. Hepatology 2010 51 : 1401 1409.
36. Kassahun WT, Hauss J. Management of combined hepatocellular and cholangiocarcinoma. Int. J. Clin. Pract. 2008 62 : 1271 1278.
37. Lee JH, Chung GE, Yu SJ et al. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J. Clin. Gastroenterol. 2010 doi: 10.1097/MCG.0b013e3181ce5dfa
38. Lee WS, Lee KW, Heo JS et al. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg. Today 2006 36 : 892 897.
39. Liu CL, Fan ST, Lo CM et al. Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch. Surg. 2003 138 : 86 90.
40. Panjala C, Senecal DL, Bridges MD et al. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am. J. Transplant. 2010 10 : 1263 1267.
41. Perkins JD. Transplanted patients with combined hepatocellular- cholangiocarcinoma: now what? Liver Transpl. 2007 13 : 1465 1466.
42. Edge SB, American Joint Committee on Cancer, American Cancer Society. AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual, 7th edn. New York : Springer, 2010.
43. Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual, 6th edn. New York : Springer, 2002.
44. Uenishi T, Kubo S, Yamamoto T et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 2003 94 : 851 857.
45. Nomoto K, Tsuneyama K, Cheng C et al. Intrahepatic cholangiocarcinoma arising in cirrhotic liver frequently expressed p63-positive basal/stem-cell phenotype. Pathol. Res. Pract. 2006 202 : 71 6.